EGLN1 induces tumorigenesis and radioresistance in nasopharyngeal carcinoma by promoting ubiquitination of p53 in a hydroxylase-dependent manner
Lu Sun(Huazhong University of Science and Technology), Guoqing Hu(Tongji Hospital)
Cited by 11
Related Papers
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial
|The Lancet|2021|234
Linkage of microbial residue dynamics with soil organic carbon accumulation during subtropical forest succession
|Soil Biology and Biochemistry|2017|186
The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors
|Journal of Hematology & Oncology|2024|157